Want to see IN:AKUMS full AI Analyst Report?
Total Valuation
Akums Drugs and Pharmaceuticals Limited has a market cap or net worth of ₹98.56B. The enterprise value is ₹75.34B.
Market Cap₹98.56B
Enterprise Value₹75.34B
Share Statistics
Akums Drugs and Pharmaceuticals Limited has 157,393,980 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding157,393,980
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Akums Drugs and Pharmaceuticals Limited’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 9.55%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)9.55%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee5.40M
Profits Per Employee458.14K
Employee Count7,536
Asset Turnover0.99
Inventory Turnover3.62
Valuation Ratios
The current PE Ratio of Akums Drugs and Pharmaceuticals Limited is 38.2. Akums Drugs and Pharmaceuticals Limited’s PEG ratio is -1.07.
PE Ratio38.2
PS Ratio1.64
PB Ratio2.15
Price to Fair Value2.32
Price to FCF7.28
Price to Operating Cash Flow―
PEG Ratio-1.07
Income Statement
In the last 12 months, Akums Drugs and Pharmaceuticals Limited had revenue of 40.71B and earned 3.38B in profits. Earnings per share was 22.60.
Revenue40.71B
Gross Profit16.05B
Operating Income3.11B
Pretax Income3.45B
Net Income3.38B
EBITDA5.29B
Earnings Per Share (EPS)22.60
Cash Flow
In the last 12 months, operating cash flow was 3.94B and capital expenditures -1.22B, giving a free cash flow of 2.72B billion.
Operating Cash Flow3.94B
Free Cash Flow2.72B
Free Cash Flow per Share17.31
Dividends & Yields
Akums Drugs and Pharmaceuticals Limited pays an annual dividend of ₹3, resulting in a dividend yield of ―
Dividend Per Share₹3
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.33
52-Week Price Change10.29%
50-Day Moving Average559.56
200-Day Moving Average482.16
Relative Strength Index (RSI)65.80
Average Volume (3m)11.50K
Important Dates
Akums Drugs and Pharmaceuticals Limited upcoming earnings date is Aug 24, 2026, Before Open (Confirmed).
Last Earnings DateMay 14, 2026
Next Earnings DateAug 24, 2026
Ex-Dividend Date―
Financial Position
Akums Drugs and Pharmaceuticals Limited as a current ratio of 2.55, with Debt / Equity ratio of ―
Current Ratio2.55
Quick Ratio1.78
Debt to Market Cap<0.01
Net Debt to EBITDA-0.02
Interest Coverage Ratio10.22
Taxes
In the past 12 months, Akums Drugs and Pharmaceuticals Limited has paid 14.76M in taxes.
Income Tax14.76M
Effective Tax Rate<0.01
Enterprise Valuation
Akums Drugs and Pharmaceuticals Limited EV to EBITDA ratio is 13.34, with an EV/FCF ratio of 36.61.
EV to Sales1.73
EV to EBITDA13.34
EV to Free Cash Flow36.61
EV to Operating Cash Flow15.18
Balance Sheet
Akums Drugs and Pharmaceuticals Limited has ₹5.82B in cash and marketable securities with ₹902.87M in debt, giving a net cash position of ₹4.94B billion.
Cash & Marketable Securities₹5.82B
Total Debt₹902.87M
Net Cash₹4.94B
Net Cash Per Share₹31.37
Tangible Book Value Per Share₹204.08
Margins
Gross margin is ―, with operating margin of 7.63%, and net profit margin of 8.31%.
Gross Margin―
Operating Margin7.63%
Pretax Margin8.48%
Net Profit Margin8.31%
EBITDA Margin13.00%
EBIT Margin9.23%
Analyst Forecast
The average price target for Akums Drugs and Pharmaceuticals Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast5.85%
EPS Growth Forecast-25.47%